series-a
Stage
1
Investors
About
Valo Therapeutics is a clinical-stage immuno-oncology company developing novel therapeutic vaccines and oncolytic viruses. Their platform technology, PeptiCRAd, is designed to activate anti-cancer immunity.
Explore Valo Therapeutics Ltd.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.